Advertisement
While oncology providers are aware of the link between obesity and cancer

Few Oncologists Refer Patients to Weight Management Programs

0
Providers need more support to refer patients to weight management, physical activity programs
Fragmentation profiles of cell-free DNA can differentiate between patients with cancer and healthy controls

Fragmentation Profiles of Cell-Free DNA Can Detect Cancer

0
Combined with mutation-based cell-free DNA analyses, 91 percent of cancer patients identified
Policies to support team-based palliative care are urgently needed to meet the growing demand for specialty palliative care

Policy Changes Proposed to Meet Projected Need for Palliative Care

0
Modeling suggests the number of palliative care physicians is decreasing
For young adults

Young Male Adults Have Lower Cancer Burden Than Women

0
Incidence of all invasive cancers decreased among men aged 20 to 49 years, increased in women
Allogeneic hematopoietic cell transplantation with an unrelated donor results in better transplantation outcomes than cord blood transplantation in acute myeloid leukemia patients with active disease

Allo-HCT With Unrelated Donor Tied to Better Outcomes in AML

0
In active AML, outcomes superior for allo-HCT with unrelated donor than for cord blood transplantation
For premenopausal women with estrogen receptor-positive

ASCO: Survival Up With Ribociclib in Advanced Breast Cancer

0
OS longer for premenopausal patients receiving ribociclib in addition to endocrine therapy
Venetoclax-obinutuzumab is associated with longer progression-free survival than chlorambucil-obinutuzumab among patients with untreated chronic lymphocytic leukemia and coexisting conditions

ASCO: Combo Regimen Effective in CLL With Coexisting Conditions

0
Progression-free survival longer with venetoclax-obinutuzumab versus chlorambucil-obinutuzumab
Maintenance therapy with olaparib is associated with improved progression-free survival in metastatic pancreatic cancer patients with a germline BRCA1 and/or BRCA2 mutation

ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer

0
Progression-free survival significantly improved with olaparib versus placebo for metastatic disease
Surgery at high-volume centers is associated with decreased local recurrence risk and improved survival for women with early-stage cervical cancer

Higher Surgical Volume May Improve Outcomes in Cervical Cancer

0
Findings show radical hysterectomy at high-volume centers tied to better survival in early cervical cancer
For frail and elderly patients with advanced gastroesophageal cancer

ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer

0
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity